The Prescription Price Scam – How Big Pharma Robs You & The Government

Jason Samir Santiago

Alright, picture this. You walk into a pharmacy, prescription in hand, and—boom—you’re hit with this absurdly high cost. Like, thirty bucks for ten pills? Or worse, sometimes even three hundred. And you’re wondering, where is all that money actually going?

Alex Monroe

It’s not going where you think. That’s for sure.

Jason Samir Santiago

Exactly. And I mean, it’s not just the pharmacy making a quick buck, right? There’s this whole tangled web behind the scenes that’s been designed—intentionally, by the way—to hike up the price. Just to bleed you dry.

Alex Monroe

Yeah, this is a system built on opacity, on outright manipulation. Most Americans don’t even understand how we got here—or why we’re paying so much more than, say, Canadians. Or people in the UK. It ties back to giant corporations, lobbying efforts, and carefully crafted legislation.

Jason Samir Santiago

It’s wild, isn’t it? Like, we’ve all accepted it—like this is just how it is. But actually, there’s layers to this scam. And what’s worse... it’s been going on for decades. DECADES.

Alex Monroe

And honestly, calling it a scam isn’t even hyperbole. When you actually look into how these companies operate, it becomes painfully clear: many of these companies practically view patients as ATMs.

Jason Samir Santiago

Right! And yet, you’ve got people defending it, saying, oh, it’s just capitalism at work. But when the system’s rigged behind closed doors, is it really capitalism anymore?

Alex Monroe

It’s more like cronyism. You’ve got private profits ballooning at the expense of public health. And the government? They aren’t stopping it. In some cases, they’re complicit in it, either through inaction or poorly regulated policies.

Jason Samir Santiago

And that’s why we’re here, right? Breaking it all down. Today, we’re pulling back the curtain to show you what Big Pharma and their buddies really don’t want you to know about your prescriptions. Buckle up.

Alex Monroe

Because you’re about to find out just how deep this rabbit hole goes.

Jason Samir Santiago

So, we’ve pulled back the curtain on prescription costs, but let’s peel back another layer—insurance. You’d think it’s there to make healthcare affordable, right? But in reality, it’s often the opposite. You’re paying more for what you could sometimes get cheaper without it. How does that even begin to make sense?

Alex Monroe

It doesn’t. And that’s entirely the point. Take pharmacy benefit managers—or PBMs, as they’re called. They act as middlemen between drug manufacturers, pharmacies, and insurers. But what they really do is exploit the system by inflating prices through, well, crafty bookkeeping and hidden arrangements.

Jason Samir Santiago

Right, like—I was reading about this, and there’s this scenario that totally blows my mind. A medication could cost... what, like five bucks if you’re just paying cash. But the moment you use your insurance?

Alex Monroe

It shoots up to five hundred dollars.

Jason Samir Santiago

Exactly! Like—how? Why? How does that even happen? Is it just... greed?

Alex Monroe

In a word? Yes. But there’s more to it than just greed. These inflated costs often come from what PBMs call “rebates” or “kickbacks”—essentially money drug manufacturers pay them to ensure their products are the most profitable. The catch? These rebates don’t lower the price for patients. They artificially inflate it.

Jason Samir Santiago

And then the insurance companies come in with their co-pays—or deductibles—and you’re left paying both, while PBMs pocket the difference. It’s like a giant vacuum cleaner just sucking up cash from every angle. I mean, the government doesn’t fall for this, do they?

Alex Monroe

Oh, but they do. Medicare and Medicaid end up overpaying for the same medications, sometimes by billions annually. Taxpayer dollars essentially subsidizing overinflated prices, all because PBMs have rigged the system so thoroughly. It’s robbery in slow motion, with bureaucratic approval.

Jason Samir Santiago

Wow. So... the American patient pays, taxpayers pay. Meanwhile, PBMs and drug manufacturers are what—just laughing all the way to the bank?

Alex Monroe

That’s exactly what’s happening. And until there’s more transparency and tighter regulation, we’re stuck with a system that bleeds everyone except the profiteers.

Jason Samir Santiago

Yeah, transparency—and, you know, basic ethics—seem to be like, super foreign concepts in this industry. But hey, there’s even more to this, right? Like, what’s the deal with these so-called rebates?

Jason Samir Santiago

Right, so these rebates you mentioned—let’s break it down. Aren’t they supposed to save patients money? Like, isn’t that how they’re sold to us?

Alex Monroe

Thats what they say. But that assumption couldn’t be further from reality.

Jason Samir Santiago

Why am I not surprised?

Alex Monroe

Because it’s all a con—a carefully orchestrated system to benefit PBMs and, of course, Big Pharma. These so-called “rebates” are essentially kickbacks drug manufacturers pay PBMs to make sure their drugs get priority placement on insurance formularies.

Jason Samir Santiago

Wait—so the rebate isn’t going to the patient?

Alex Monroe

No. The patient never sees a dime of it. Instead, the PBMs use these rebates to fill their own coffers, ensuring their pockets stay fat while the patients’ prescription costs actually... go up.

Jason Samir Santiago

Unreal. And here I thought rebates were supposed to make something cheaper, not cost more.

Alex Monroe

It’s a deliberate misdirection. PBMs and insurers charge patients—and even government programs like Medicare—a higher price, claiming they’re passing on the savings. But the truth is, they’re keeping the lion’s share of those rebates while falsely inflating drug prices in the process.

Jason Samir Santiago

Honestly, it makes my blood boil. And what about the pharmacies themselves? They’re just stuck in the middle, right?

Alex Monroe

Exactly. Independent pharmacies—those family-owned corner drugstores—are hit the hardest. PBMs dictate the reimbursement rates they pay pharmacies, and those rates are often so low that many pharmacies can’t even break even. It’s driving them, one by one, out of business.

Jason Samir Santiago

Let me get this straight—PBMs charge the insurers more, pay the pharmacies less, and then get to pocket the difference? That’s insane. It—it doesn’t even feel legal. Is it legal?

Alex Monroe

Unfortunately, it is. PBMs have mastered feathering their nests through loopholes, legislative gray areas, and straight-up lobbying. Their entire business model relies on keeping drug pricing as confusing and opaque as possible, so nobody—not patients, not pharmacies—can hold them accountable.

Jason Samir Santiago

And of course, the big players—the massive corporations—come out on top while everyone else gets crushed. I mean, what chance does the little guy have against a system so rigged?

Alex Monroe

Very little, unfortunately. Which is why, without federal reform or stricter oversight, PBMs will continue exploiting the system unchecked—and patients will keep paying the price, literally and figuratively.

Jason Samir Santiago

It’s just wild to me how much damage they’ve done—not just to patients, but to entire communities that rely on those independent pharmacies you mentioned. Like, this is affecting way more than just wallets.

Jason Samir Santiago

It’s maddening, isn’t it? And as if screwing over patients and pharmacies wasn’t enough, they’re also hitting the government where it hurts—billions of taxpayer dollars are being siphoned off through their scams.

Alex Monroe

Yeah, and what’s truly disturbing is just how deeply entrenched this fraud is. Medicare and Medicaid—the programs meant to protect the most vulnerable—are being drained through systemic overbilling and price manipulation.

Jason Samir Santiago

And they do this how? By jacking up the numbers they report?

Alex Monroe

Exactly. PBMs inflate the reported drug costs to Medicare and Medicaid while at the same time cutting reimbursement rates to pharmacies. They essentially fabricate a higher cost to the government and pocket the difference. It’s theft—plain and simple.

Jason Samir Santiago

And the government just... lets this happen?

Alex Monroe

Sadly, yes. The way these contracts are written, they obscure the actual cost of drugs. PBMs claim they’re negotiating for savings, but in reality, they control the pricing model entirely. That means no one—not even regulators—can see the true costs.

Jason Samir Santiago

So PBMs are writing the rules and running the game. Talk about conflict of interest.

Alex Monroe

It’s worse than that. When fraud is discovered, it often results in settlements that are just a fraction of the actual amount stolen. No one faces real consequences. And these companies? They simply treat the fines as a cost of doing business.

Jason Samir Santiago

Unreal. Do you have an example of this happening?

Alex Monroe

Sure. There’s a settlement involving one of the largest PBMs—they overcharged Medicaid for prescription drugs and ended up paying a $65 million fine. But here’s the kicker: the fraud itself likely totaled hundreds of millions. That fine? It didn’t even make a dent in their bottom line.

Jason Samir Santiago

So they basically made a profit off of getting caught. That’s—that’s insane. And no one’s shutting them down?

Alex Monroe

No, because they’ve embedded themselves so deeply into the system, dismantling their control would require monumental effort and political will—two things that, so far, have been in short supply.

Jason Samir Santiago

Man, every time I think this story can’t get worse, it does. It’s mind-blowing how blatant this all is.

Jason Samir Santiago

You know, Alex, just when I think this fraud can’t get any worse, something else comes to mind—insulin. This drug’s been saving lives for over a century, right? Discovered back in 1921, its creator even sold it for 1 dollar to make sure it was accessible to everyone. And yet here we are, paying over three hundred bucks for something that used to cost twenty. How is that even possible?

Alex Monroe

It’s not just possible, Jason—it’s by design. Insulin, despite being a life-essential drug for millions of diabetics, has become one of the poster children for pharmaceutical price gouging. The reason it’s three hundred dollars now comes down to market monopolies, patent manipulations, and, of course, the dark role PBMs play in the process.

Jason Samir Santiago

Three hundred freaking dollars! Like, it blows my mind. And what makes it even worse is... people are rationing this stuff. People are literally dying because they can’t afford something that’s been around for a hundred years.

Alex Monroe

Exactly. The high cost forces patients, especially those without insurance, to make heartbreaking decisions—ration their insulin, skip doses, or even forgo it entirely. And while patient lives hang in the balance, PBMs and drug manufacturers are busy counting their profits.

Jason Samir Santiago

Unreal. And those PBMs—you know, those middlemen we keep talking about—they’re just, what, soaking up rebates? Profiting off people’s pain?

Alex Monroe

That’s part of it, but the system is more insidious than just rebates. PBMs essentially control which drugs are covered by insurance. They negotiate “preferred placement” deals with manufacturers, which means insulin brands pay hefty rebates—kickbacks, really—to PBMs for exclusive access. Meanwhile, those costs are passed directly to the patient in the form of higher list prices.

Jason Samir Santiago

Wait—so these guys are hiking prices on purpose? Knowing full well it’ll crush anyone without deep pockets?

Alex Monroe

That’s exactly what’s happening. And here’s where it gets even worse: despite multiple insulin manufacturers out there, competition has been deliberately squashed. Patents are continuously extended through minor tweaks, blocking the introduction of cheaper, generic alternatives. It’s a practice known as “evergreening.”

Jason Samir Santiago

Evergreening? Ugh. Sounds slimy. Like Hilary Clinton, her code name was Evergreen. So they’re gaming the system to keep cheaper options off the shelves?

Alex Monroe

That’s right. And regulators have allowed it. Generic insulin could drastically lower costs, but manufacturers, PBMs, and, frankly, Congress, have put up roadblocks at every turn. The FDA’s approval process is sluggish, and drug makers leverage lawsuits to delay generics from entering the market for years.

Jason Samir Santiago

And Congress? Oh man, don’t even get me started on Congress. They’re out here holding hearings, pretending to fight for lower drug prices, but then—boom—nothing changes. Why?

Alex Monroe

Because lobbyists for PBMs, pharmaceutical companies, and even insurers are incredibly influential. They pour millions into campaign contributions and lobbying efforts to ensure legislation stays toothless. Congress, frankly, spends more time posturing than actually fixing the root problem.

Jason Samir Santiago

So, all the outrage, the viral tweets... it’s just noise? Meanwhile, the system stays broken?

Alex Monroe

For the most part, yes. Public outcry does lead to hearings, and occasionally there are some minor reforms. But the core infrastructure—the way PBMs control pricing and how patent laws are manipulated—remains untouched. It’s calculated, it’s profitable, and it’s entirely legal.

Jason Samir Santiago

Man, if this doesn’t get under your skin... I don’t know what will.

Jason Samir Santiago

You know, Alex, the more we dig into this madness, the clearer it gets. It’s not just some faceless system causing all this suffering—it’s the big players driving this chaos. CVS Caremark, Express Scripts, OptumRx. Between those three? They control, like, 80% of the entire market. That’s insane.

Alex Monroe

It is. These PBMs have consolidated so much power that they’re essentially gatekeepers for the entire pharmaceutical supply chain. If you’re a drug manufacturer or a pharmacy, you can’t avoid them. You’ve got to play by their rules—or you’re out of the game entirely.

Jason Samir Santiago

And those rules? Totally stacked against everyone else. The patients, the pharmacies—heck, maybe even the manufacturers sometimes. It’s like these PBMs have turned the entire system into their personal playground.

Alex Monroe

And what enables them to stay so dominant? Money and political influence. These companies pump millions of dollars into lobbying efforts—and not just on one side of the aisle, mind you. Both Republicans and Democrats are taking their checks.

Jason Samir Santiago

Of course they are. Because why fix a broken system when you can profit off it, right? They’re all busy stuffing their pockets while the rest of us can barely afford antibiotics.

Alex Monroe

It’s even worse than that. The lobbying isn’t just maintaining the status quo—it’s actively blocking any meaningful reform. Take those “price transparency” bills you hear politicians grandstanding about.

Jason Samir Santiago

Yeah, I’ve seen those. They sound good, like they’re gonna fix everything. But then... nothing changes. What’s the deal?

Alex Monroe

The deal is, they’re designed to fail. These bills are usually watered down by the time they pass—if they pass at all. They might require a company to report some pricing data, but they don’t mandate lower prices or end the opaque rebate schemes.

Jason Samir Santiago

So it’s all just smoke and mirrors? A big performance so politicians can say, “Hey, we tried,” while doing absolutely nothing? Typical.

Alex Monroe

Exactly. And PBMs know how to work the system. They exploit loopholes in these weak regulations while continuing business as usual—overcharging patients and driving small pharmacies out of existence. It’s a well-oiled machine, fueled by lobbying dollars and political complacency.

Jason Samir Santiago

Man, it’s like—how deep does this go? Or maybe the better question is, how do we even begin to untangle it?

Alex Monroe

You’re right, Jason. This system is so tangled, it’s hard to see where to even start. But we can’t just keep exposing the problem without talking about solutions. What has to change for this exploitation to finally end?

Jason Samir Santiago

The first step? Abolish or heavily regulate PBMs. These entities have proven, time and again, that their role as “middlemen” does far more harm than good. Look, some folks argue they negotiate savings—but the truth is, their business model thrives on opacity and manipulation.

Alex Monroe

So, no PBMs. But let’s be real—how do we even make that happen? Is it even possible?

Jason Samir Santiago

It is, but it’s going to take federal legislation with actual teeth. For starters, we need to ban spread pricing—that’s where PBMs charge insurers one inflated price, reimburse pharmacies at a much lower rate, and keep the difference as profit. And then there’s rebates. All rebates should go to patients, period.

Alex Monroe

Okay, okay—I like this. Transparency. Accountability. Actual reforms. But what about right now? What can regular people even do while waiting for Congress to, you know, wake up?

Jason Samir Santiago

One practical step—buying prescriptions with cash can sometimes be cheaper than using insurance. I know that sounds counterintuitive, but there are apps and tools that help you compare prices. The system’s broken, but you can still find ways to avoid the worst of it.

Alex Monroe

And what about pharmacies? I mentioned independent ones earlier. Are they doing anything to fight back?

Jason Samir Santiago

Absolutely. Many independent pharmacies are banding together to challenge PBM monopolies. They’re forming networks, advocating for fair reimbursements, and pushing state legislators to enact PBM reforms. Supporting local pharmacies over chains can actually make a difference.

Alex Monroe

Man, I love that. It’s the little guy punching back, you know? But it still feels like an uphill battle.

Jason Samir Santiago

It is. But if enough people push for real change, even the most entrenched systems can be challenged. That’s why awareness is key—people need to understand how this works and demand better, both from the government and the companies profiting off this chaos.

Alex Monroe

Alright, listeners, you heard the man—get informed, get loud, and don’t settle for the status quo. Oh, and make sure you’re shopping smart, supporting local pharmacies, and, honestly, calling out the BS whenever you see it.

Jason Samir Santiago

And don’t forget—every voice adds up. Push for laws that prioritize patients over profits. It might sound ambitious, but nothing changes without pressure. And the more of us behind that pressure, the more likely we are to see a shift.

Alex Monroe

Yeah, and, guys, if you found this episode enlightening, maddening, or maybe just eye-opening? Go ahead—like, subscribe, share it with that one friend who loves a good rant about Big Pharma. Let’s keep this conversation going.

Alex Monroe

Because at the end of the day, knowledge really is power. And the more informed we are, the harder it becomes for these companies to keep getting away with it.

Jason Samir Santiago

On that note, folks, we’re wrapping it up here. It’s been real, it’s been infuriating, and honestly—it’s been fun, too. Until next time!

Alex Monroe

Take care, everyone, and stay informed.